[1] 中华医学会肝病学分会.胆汁淤积性肝病管理指南(2021). 临床肝胆病杂志,2022,38:62-69.
[2] Jacquemin E. Progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol, 2012,36 Suppl 1:S26-535.
[3] Pawlikowska L, Strautnieks S, Jankowska I, et al. Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol,2010,53:170-178.
[4] Heubi JE, Setchell KDR, Bove KE. Inborn Errors of Bile Acid Metabolism. Clin Liver Dis, 2018,22:671-687.
[5] Avena A, Puggelli S, Morris M, et al. ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed. Dig Liver Dis,2021,53:329-344.
[6] Zhang J, Yang Y, Gong JY, et al. Low-GGT intrahepatic cholestasis associated with biallelic USP53 variants: Clinical, histological and ultrastructural characterization. Liver Int, 2020,40:1142-1150.
[7] Qiu YL, Gong JY, Feng JY, et al. Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis. Hepatology,2017,65:1655-1669.
[8] Gonzales E, Hardikar W, Stormon M, et al. Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study. Lancet,2021,398:1581-1592.
[9] Thakurdas SM, Lopez MF, Kakuda S, et al. Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi). Hepatology,2016,63:550-565.
[10] Adams JM, Huppert KA, Castro EC, et al. Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome. Hepatology,2020,71:1331-1349.
[11] Cheng JB, Jacquemin E, Gerhardt M, et al. Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease. J Clin Endocrinol Metab,2003,88:1833-1841.
[12] Mack CL, Feldman AG, Sokol RJ. Clues to the etiology of bile duct injury in biliary atresia. Semin Liver Dis,2012,32:307-316.
[13] Bezerra JA, Wells RG, Mack CL, et al. Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century. Hepatology,2018,68:1163-1173.
[14] Berauer JP, Mezina AI, Okou DT, et al. Identification of Polycystic Kidney Disease 1 Like 1 Gene Variants in Children With Biliary Atresia Splenic Malformation Syndrome. Hepatology,2019,70:899-910.
[15] Fabris L, Fiorotto R, Spirli C, et al. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases. Nat Rev Gastroenterol Hepatol,2019,16:497-511.
[16] Staufer K. Current Treatment Options for Cystic Fibrosis-Related Liver Disease. Int J Mol Sci,2020,21:8586. |
